About Adipo Therapeutics
Adipo Therapeutics is a private company based in Indianapolis, Indiana. It has reported $5,967,337 raised in two offerings on Form D since September 2020. Its chief executive is Karen Wurster.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2024 | Dec 11, 2024 | $4,717,337of $14.7M target | 20 | $235K | EquityRule 506(b) | Form D ↗ |
| Aug 18, 2020 | Sep 2, 2020 | $1,250,000of $2.0M target | 2 | $625K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $5,967,337 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Adipo Therapeutics's Form D filed Dec 11, 2024.
KJ
Keith Johns
Executive officer
KW
Karen Wurster
CEO and director
MD
Meng Deng
Director
MC
Michael Clayman
Director